DESCRIPTION:

List of positional candidate genes after correcting for multiple testing and controlling the false discovery rate from genome wide association studies (GWAS) retrieved from the NHGRI-EBI Catalog of published genome-wide association studies (http://www.ebi.ac.uk/gwas/). The disease/trait examined in this study, as reported by the authors, was Graves' disease. The EFO term Graves disease was annotated to this set after curation by NHGRI-EBI. Intergenic SNPS were mapped to both the upstream and downstream gene. P-value uploaded. This gene set was generated using gwas2gs v. 0.1.8 and the GWAS Catalog v. 1.0.1.

LABEL:

GWAS: Graves disease

SCORE TYPE:

P-Value

DATE ADDED:

2017-05-02

DATE UPDATED:

2024-04-25

SPECIES:

AUTHORS:

X Chu, CM Pan, SX Zhao, J Liang, GQ Gao, XM Zhang, GY Yuan, CG Li, LQ Xue, M Shen, W Liu, F Xie, SY Yang, HF Wang, JY Shi, WW Sun, WH Du, CL Zuo, JX Shi, BL Liu, CC Guo, M Zhan, ZH Gu, XN Zhang, F Sun, ZQ Wang, ZY Song, CY Zou, WH Sun, T Guo, HM Cao, JH Ma, B Han, P Li, H Jiang, QH Huang, L Liang, LB Liu, G Chen, Q Su, YD Peng, JJ Zhao, G Ning, Z Chen, JL Chen, SJ Chen, W Huang, HD Song

TITLE:

A genome-wide association study identifies two new risk loci for Graves' disease.

JOURNAL:

Nature genetics Aug 2011, Vol 43, pp. 897-901

ABSTRACT:

Graves' disease is a common autoimmune disorder characterized by thyroid stimulating hormone receptor autoantibodies (TRAb) and hyperthyroidism. To investigate the genetic architecture of Graves' disease, we conducted a genome-wide association study in 1,536 individuals with Graves' disease (cases) and 1,516 controls. We further evaluated a group of associated SNPs in a second set of 3,994 cases and 3,510 controls. We confirmed four previously reported loci (in the major histocompatibility complex, TSHR, CTLA4 and FCRL3) and identified two new susceptibility loci (the RNASET2-FGFR1OP-CCR6 region at 6q27 (P(combined) = 6.85 × 10(-10) for rs9355610) and an intergenic region at 4p14 (P(combined) = 1.08 × 10(-13) for rs6832151)). These newly associated SNPs were correlated with the expression levels of RNASET2 at 6q27, of CHRNA9 and of a previously uncharacterized gene at 4p14, respectively. Moreover, we identified strong associations of TSHR and major histocompatibility complex class II variants with persistently TRAb-positive Graves' disease. PUBMED: 21841780
Find other GeneSets from this publication